Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Educational Status × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 11 Breast Neoplasms 11 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Neoplasm Metastasis 4 Hematologic Neoplasms 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Hematopoietic and Lymphatic System Neoplasm 3 Carcinoma, Non-Small-Cell Lung 3 Skin Carcinoma 2 Pancreatic Neoplasms 2 Lymphoma 2 Breast Carcinoma In Situ 2 Anatomic Stage I Breast Cancer AJCC v8 2 Advanced Malignant Solid Neoplasm 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Overweight 1 Opioid-Related Disorders 1 Obesity-Related Malignant Neoplasm 1 Obesity 1 Myeloproliferative Disorders 1

Interventions

pembrolizumab 27 enfortumab vedotin 16 Nivolumab 14 Gemcitabine 12 avelumab 10 Magnetic Resonance Spectroscopy 10 Cisplatin 10 Carboplatin 10 Specimen Handling 9 sacituzumab govitecan 6 atezolizumab 6 durvalumab 5 Ipilimumab 5 Docetaxel 5 Paclitaxel 4 cabozantinib 3 Taxes 3 tislelizumab 2 relatlimab 2 lenvatinib 2 erdafitinib 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Cryosurgery 2 CTLA-4 Antigen 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡